NCT03978091: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03978091 |
|---|---|
| Title | A Phase 1, Open-Label Study in Healthy Adults to Evaluate the Safety and Pharmacokinetics of AVYCAZ(R) in Combination With Aztreonam (COMBINE) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 9, 2019 |
| Completion date | Nov. 23, 2020 |
| Required reporting date | Nov. 23, 2021, midnight |
| Actual reporting date | Nov. 23, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |